GGrantIndex
← Leaderboards

Daniel Rogers Burnett

Theranova, Llc

Google Scholar ↗PubMed ↗ORCID ↗
$18,342,595
Attributed
$25,245,955
Total exposure
25
Grants
22
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY2011–25
$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,245,955 · 25

By mechanism

R44$18,741,308 · 10
R43$4,289,518 · 14
SB1$2,215,129 · 1

Top collaborators

Most similar at Theranova, Llc

Same institution · by research overlap

Others in their field

Top investigators on “Devices”

Research focus

DevicesClinical ResearchFutureBaseCostMonitorLocationInnovationLeadPositioning AttributeFamily SuidaeCathetersPreventMedicalUnited StatesAdverse EventAdoptionSmall Business Innovation Research GrantMeasurementDesignAmericanAlgorithmsDetectionCritical Illness

Grant awards (40)

A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location$776,367
SB1 · FY2025 · AG · contact PI
A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location$1,438,762
SB1 · FY2024 · AG · contact PI
SoleStim Neuromodulation System, a home-use device for the treatment of dysmenorrhea$343,510
R43 · FY2024 · HD · contact PI
A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location$653,381
R44 · FY2023 · AG · contact PI
A Photo-based Menstrual Blood Loss Metric$608,576
R44 · FY2023 · HD · contact PI
An Intraperitoneal Insulin Delivery System for Management of Type 1 Diabetes$1,048,080
R44 · FY2022 · DK
A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location$1,004,449
R44 · FY2022 · AG · contact PI
A Photo-based Menstrual Blood Loss Metric$721,899
R44 · FY2022 · HD · contact PI
A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population$575,818
R44 · FY2022 · HD · contact PI
An Intraperitoneal Insulin Delivery System for Management of Type 1 Diabetes$993,339
R44 · FY2021 · DK
Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder$910,489
R44 · FY2021 · AA · contact PI
A Photo-based Menstrual Blood Loss Metric$717,254
R44 · FY2021 · HD · contact PI
A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population$593,142
R44 · FY2021 · HD · contact PI
Empower Neuromodulation System, a home-use device for the treatment of anxiety disorders$302,951
R43 · FY2021 · AT · contact PI
A Non-Invasive Neuromodulation Device for In-Home Treatment of Overactive Bladder$72,845
R44 · FY2021 · AG · contact PI
A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population$765,005
R44 · FY2020 · HD · contact PI
A Non-Invasive Neuromodulation Device for In-Home Treatment of Overactive Bladder$687,183
R44 · FY2020 · AG · contact PI
A Novel, Low-Cost Device to Guide Peripherally Inserted Central Catheter (PICC) Line Placement$561,565
R44 · FY2020 · AG
A Device for the Prevention and Treatment of Multiple Organ Failure in COVID-19 Patients$398,966
R44 · FY2020 · AG · contact PI
A Novel, Low-Cost Device to Guide Peripherally Inserted Central Catheter (PICC) Line Placement$915,143
R44 · FY2019 · AG
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women$855,031
R44 · FY2019 · AG · contact PI
A Non-Invasive Neuromodulation Device for In-Home Treatment of Overactive Bladder$806,779
R44 · FY2019 · AG · contact PI
A Novel Nasogastric Feeding Tube for Optimizing Nutritional Administration in Neonatal and Pediatric Patients$224,931
R43 · FY2019 · HD · contact PI
Non-invasive Neuromodulation Device for Decreasing Withdrawal Symptoms and Craving during Treatment of Opioid Use Disorder$223,176
R43 · FY2019 · DA · contact PI
A Novel Device for Optimal and Personalized Fluid Therapy in Septic Shock Patients$1,224,065
R44 · FY2018 · GM · contact PI
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women$1,146,609
R44 · FY2018 · AG · contact PI
A Novel Transurethral Cryotherapy Catheter System to Treat Benign Prostate Hyperplasia$318,230
R43 · FY2018 · AG · contact PI
A Novel, Low-Cost Device to Guide Peripherally Inserted Central Catheter (PICC) Line Placement$224,551
R43 · FY2018 · AG · contact PI
Neural Modulation System for In-Home Treatment of Overactive Bladder$224,534
R43 · FY2018 · AG · contact PI
A Novel, Low-Cost Device to Guide Peripherally Inserted Central Catheter (PICC) Line Placement in Pediatric and Neonatal Patients$224,445
R43 · FY2018 · HD · contact PI
A Novel Device for Optimal and Personalized Fluid Therapy in Septic Shock Patients$1,685,221
R44 · FY2017 · GM · contact PI
A Novel Nasogastric Feeding Tube for Optimizing Nutritional Administration in Older Adults$224,919
R43 · FY2017 · AG · contact PI
A novel device for improving sepsis outcomes through hemodynamic optimization$798,113
R44 · FY2016 · GM · contact PI
Non-Invasive Device to Remotely Monitor Cardiac Function and Reduce Cost of Managing Heart Failure Patients$309,279
R43 · FY2016 · HL · contact PI
A novel device for improving sepsis outcomes through hemodynamic optimization$998,356
R44 · FY2015 · GM · contact PI
Continuous hemodynamic monitoring device for improving pediatric sepsis outcomes$219,304
R43 · FY2014 · HD · contact PI
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women$217,425
R43 · FY2014 · AG · contact PI
A novel device for improving sepsis outcomes through hemodynamic optimization$224,666
R43 · FY2013 · GM · contact PI
Improving the Kinetics and Reliability of Continuous Glucose Monitoring$476,155
R43 · FY2012 · DK
Improving the Kinetics and Reliability of Continuous Glucose Monitoring$531,442
R43 · FY2011 · DK